eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Michael C. Cimino, Ph.D. - Comment

Michael C. Cimino, Ph.D. - Comment

Document ID: FDA-2009-N-0519-0014
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: January 22 2010, at 02:30 PM Eastern Standard Time
Date Posted: January 25 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: November 3 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: February 24 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80a825ce
View Document:  View as format xml

View Comment

See attached file for (A) comparison of revised ICH scheme to other existing mutagenicity test schemes worldwide, (B) issues about animal testing, and (C) other adverse effects of mutagenicity besides cancer.

Attachments:

Michael C. Cimino, Ph.D. - Comment

Title:
Michael C. Cimino, Ph.D. - Comment

View Attachment: View as format msw8

Related Comments

    View All
Total: 8
Robert H. Heflich, Division of Genetic and Reproductive Toxicology, U.S. FDA/NCTR - Testimony
Public Submission    Posted: 01/20/2010     ID: FDA-2009-N-0519-0010

Feb 24,2010 11:59 PM ET
Michael C. Cimino, Ph.D. - Comment
Public Submission    Posted: 01/25/2010     ID: FDA-2009-N-0519-0014

Feb 24,2010 11:59 PM ET
Michael C. Cimino, Ph.D. - Comment
Public Submission    Posted: 01/25/2010     ID: FDA-2009-N-0519-0015

Feb 24,2010 11:59 PM ET
U.S. FDA/National Center for Toxicological Research - Testimony
Public Submission    Posted: 03/05/2010     ID: FDA-2009-N-0519-0025

Feb 24,2010 11:59 PM ET
Rosalie Elespuru, PhD - Testimony
Public Submission    Posted: 01/19/2010     ID: FDA-2009-N-0519-0009

Feb 24,2010 11:59 PM ET